4
Changes in Ownership
PDS Biotechnology Corp Filed Acc 0001127602-17-031249
President and CEO sold 7,500 shares at an average $10.91 ($81,800)
From the SEC's structured data for this filing
Trades in this filing
Leuthner Brian A · President and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-11-01 | Sale : show line 1 in the form | −2,500 | $10.92 | $27,300 | 102,736 | D |
| 2017-11-02 | Sale : show line 2 in the form | −2,500 | $10.94 | $27,350 | 100,236 | D |
| 2017-11-03 | Sale : show line 3 in the form | −2,500 | $10.86 | $27,150 | 97,736 | D |
| Open-market sales · 7,500 sh · avg $10.91 · $81,800 | ||||||
Loading xslF345X03/form4.xml…